retatrutide maker - “Triple G” New Weight Loss Drugs: Beyond
Description
In addition, CBD demonstrates opposite effects to THC on CB1 receptors, which allows control of adverse effects when used in combination
Novel Indications Trials are underway to assess GLP-1 efficacy in areas such as sleep apnea, cardiovascular risk reduction, neurodegenerative diseases (e.g., Alzheimers, Parkinsons), and womens health conditions like PCOS
With a growing number of patients using these medications for diabetes or to meet certain optimization goals before undergoing hip and knee reconstructive surgery, our aim was to establish evidence-based guidelines on when to discontinue these to enhance patient safety and surgical success. The study, Optimal Timing for Cessation of GLP-1 Agonist Before Elective Total Hip and Knee Arthroplasty, obtained data from the TriNetX Research Network, a multi-institutional national aggregated database, to identify patients who underwent TKA or THA from January 1, 2018 to January 1, 2023
No guaranteed results
